Oloumak

Oloumak is a campaign spearheaded by the Ministry of Investment Saudi Arabia (MISA) and Janssen, the pharmaceuticals companies of Johnson & Johnson, in collaboration with key KSA government entities.

Vision

As one of the most dynamic countries in the world, Saudi Arabia is at the centre of innovation and growth. By offering a robust economic ecosystem and world-class facilities, the Kingdom seeks to establish itself as a trusted global partner for companies looking to boost their innovation capabilities in the region and beyond.

MISA Role

In line with Saudi Vision 2030, The Ministry of Investment of Saudi Arabia (MISA) is taking a leading role in improving Saudi Arabia’s overall business environment by facilitating access and developing a vibrant cross-government investment ecosystem, while supporting businesses throughout their investment journey.

A Quote from MISA Leadership

Innovation is the lifeblood of businesses and economies. In this context, it is of strategic importance for the public and private sector to work hand-in-hand to accelerate sustainable economic growth and build a vibrant community of the future.

Oloumak — The Value of Innovation

Oloumak is a campaign spearheaded by the Ministry of Investment Saudi Arabia (MISA) and Janssen, the pharmaceuticals companies of Johnson & Johnson, in collaboration with key KSA government entities.

Under one umbrella brand, we demonstrate the value of innovation in healthcare for Saudi Arabia’s economy, citizens and residents and highlight the efforts towards improving Saudi’s healthcare innovation ecosystem.

Strategic Pillars of Oloumak

Innovation

Innovation in the Kingdom’s healthcare sector is integral as it contributes to saving and extending lives, as well as strengthens the nation’s overall economy.

Collaboration

Self-reliance in the supply of innovative healthcare solutions through collaboration between public and private sector enables a robust domestic Saudi pharma manufacturing capacity and sustains a culture of innovation within the Kingdom.

Quality of Life

Supporting national intellectual capacity development by investing in R&D and innovative healthcare solutions can yield a high quality of life for the Kingdom’s patients benefiting from the solutions and for the nation’s workforce, who benefit from education and upskilling.

R&D in Healthcare

Continual investment in R&D is critical for ongoing healthcare innovations and meeting evolving healthcare needs of societies in the Kingdom.

Patient and Healthcare Outcomes

Investment in healthcare is critical to safeguard societies in the Kingdom from evolving or unforeseen diseases and improve healthcare outcomes.